Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Weidinger S, Bewley A, Hong HC, Silvestre JF, et al. Predicting success with reduced dosing frequency of tralokinumab in patients with moderate-to-severe atopic dermatitis. Br J Dermatol 2024 Dec 5:ljae439. doi: 10.1093.
PMID: 39657020


Privacy Policy